ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,588Medicare Part D Prescriptions Filled, Including Refills

Rank: 512 out of 3593

$381K Total Retail Price of All Prescriptions

Rank: 1026 out of 3593

474 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
40% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 474 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

7% of this provider’s 474 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,584 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 658 547 1 1
LISINOPRIL 467 376 2 2
LEVOTHYROXINE SODIUM 462 368 3 4
HYDROCHLOROTHIAZIDE 400 330 4 10
OMEPRAZOLE 372 310 5 5
AMLODIPINE BESYLATE 369 313 6 3
METFORMIN HCL 250 208 7 6
ALENDRONATE SODIUM 242 226 8 22
METOPROLOL TARTRATE 235 197 9 8
LOSARTAN POTASSIUM 234 202 10 14
ATENOLOL 199 191 11 11
PRAVASTATIN SODIUM 195 160 12 13
WARFARIN SODIUM 173 162 13 18
ATORVASTATIN CALCIUM 155 128 14 15
GLIPIZIDE 153 145 15 40
FUROSEMIDE 152 126 16 9
CRESTOR 130 104 17 21
CARVEDILOL 122 100 18 23
TRAMADOL HCL 118 102 19 17
LOVASTATIN 116 107 20 20
HYDROCODONE-ACETAMINOPHEN 113 86 S3 21 7
GLIPIZIDE ER 104 97 22 101
PROAIR HFA 99 79 23 54
ZOLPIDEM TARTRATE 98 70 24 12
SERTRALINE HCL 95 68 25 28
ALPRAZOLAM 95 68 25 37
MELOXICAM 93 88 27 29
TEMAZEPAM 88 66 28 56
RANITIDINE HCL 85 64 29 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 54 30 26
POTASSIUM CHLORIDE 79 69 31 24
FINASTERIDE 74 74 32 79
GABAPENTIN 72 50 33 16
LORAZEPAM 72 54 33 98
NIFEDIPINE ER 68 68 35 75
CITALOPRAM HBR 66 59 36 25
GLYBURIDE 64 34 R 37 55
TERAZOSIN HCL 63 63 38 115
MECLIZINE HCL 63 52 38 96
ADVAIR DISKUS 62 49 40 47
BENAZEPRIL HCL 62 60 40 69
SPIRIVA 61 49 42 87
VERAPAMIL ER 61 49 42 99
AMOXICILLIN 59 45 44 128
ALLOPURINOL 59 48 44 35
METOPROLOL SUCCINATE 57 57 46 19
DIOVAN 56 40 47 46
CAPTOPRIL 56 56 47 213
TAMSULOSIN HCL 55 52 49 33
PAROXETINE HCL 54 37 50 62
CLOPIDOGREL 54 43 50 30
PANTOPRAZOLE SODIUM 53 42 52 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 48 52 102
AZITHROMYCIN 52 32 54 34
DOXAZOSIN MESYLATE 52 42 54 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.